Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
97.74 USD | +1.02% | -1.55% | +11.83% |
May. 15 | Walgreens to Sell Over-the-Counter Naloxone Anti-Narcotic Spray to Reverse Opioid Overdoses | MT |
May. 09 | Truist Adjusts HCI Group's Price Target to $140 From $130, Keeps Buy Rating | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by -100% by 2026.
- The group's high margin levels account for strong profits.
- Its low valuation, with P/E ratio at 9.08 and 8.82 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Property & Casualty Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.83% | 1.01B | C- | ||
+52.48% | 70.83B | B- | ||
+13.14% | 51.98B | C+ | ||
+10.05% | 48.17B | B | ||
+16.75% | 43.31B | B- | ||
+35.79% | 38.03B | B- | ||
+71.15% | 34.38B | B | ||
+12.02% | 29.73B | B- | ||
+25.37% | 25.43B | C- | ||
+0.73% | 21.8B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HCI Stock
- Ratings HCI Group, Inc.